How big is the Gastrointestinal Therapeutics Market?

The Gastrointestinal Therapeutics Market size is expected to reach USD 40.20 billion in 2024 and grow at a CAGR of 4.34% to reach USD 49.80 billion by 2029. Read More

What is the current Gastrointestinal Therapeutics Market size?

In 2024, the Gastrointestinal Therapeutics Market size is expected to reach USD 40.20 billion. Read More

Who are the key players in Gastrointestinal Therapeutics Market?

Abbvie Inc., AstraZeneca, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.) and Johnson & Johnson(Janssen Global Services LLC) are the major companies operating in the Gastrointestinal Therapeutics Market. Read More

Which is the fastest growing region in Gastrointestinal Therapeutics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Gastrointestinal Therapeutics Market?

In 2024, the North America accounts for the largest market share in Gastrointestinal Therapeutics Market. Read More

What years does this Gastrointestinal Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Gastrointestinal Therapeutics Market size was estimated at USD 38.46 billion. The report covers the Gastrointestinal Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gastrointestinal Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Gastrointestinal TherapeuticsCompanies

This report lists the top Gastrointestinal Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Gastrointestinal Therapeutics industry.